Aug 01, 2022 / NTS GMT
Presentation
Aug 01, 2022 / NTS GMT
=====================
Corporate Participants
=====================
* Bernhardt G. Zeiher
Astellas Pharma Inc. - Chief Medical Officer & President of Development
* Hiromitsu Ikeda
* Minoru Kikuoka
Astellas Pharma Inc. - CFO & Senior Managing Executive Officer
* Yukio Matsui
Astellas Pharma Inc. - Chief Commercial Officer & Senior Corporate Executive
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research Division - Senior Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Astellas Pharma Inc
(TSE:4503)
円
2,196.5
+45.5 (+2.12%)
Market Cap: 3.94 Tn
Enterprise Value: 4.21 Tn
PE Ratio: 13.54
PB Ratio: 2.15
GF Score: 82/100 Q1 2023 Astellas Pharma Inc Earnings Presentation Transcript
Aug 01, 2022 / NTS GMT
Release Date Price:
円2062.5
(-1.20%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot